dalteparin and tgx 221

dalteparin has been researched along with tgx 221 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Angus, JA; Jones, C; Sturgeon, SA; Wright, CE1

Other Studies

1 other study(ies) available for dalteparin and tgx 221

ArticleYear
Advantages of a selective beta-isoform phosphoinositide 3-kinase antagonist, an anti-thrombotic agent devoid of other cardiovascular actions in the rat.
    European journal of pharmacology, 2008, Jun-10, Volume: 587, Issue:1-3

    Topics: Animals; Anticoagulants; Bleeding Time; Blood Pressure; Cardiovascular Agents; Enoxaparin; Enzyme Inhibitors; Fibrinolytic Agents; Heart Rate; Male; Mesenteric Arteries; Morpholines; Muscle Relaxation; Muscle, Smooth, Vascular; Phosphoinositide-3 Kinase Inhibitors; Platelet Activation; Platelet Aggregation Inhibitors; Pyrimidinones; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Stress, Physiological; Substrate Specificity; Vascular Resistance

2008